• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 12
      Evolving Risk of Urinary Adverse Events Across Localized Prostate Cancer Treatments: A Propensity-weighted Analysis of Surveillance, Epidemiology and End Results-Medicare Data - PubMed - 7 day(s) ago

      Prostate cancer treatments can cause long-term urinary adverse events (UAEs), but time-varying risks across treatments remain understudied. Using Surveillance, Epidemiology and End Results-Medicare data, we evaluated men aged ≥66 yr with localized prostate cancer treated with radical prostatectomy ( …

      Source: pubmed.ncbi.nlm.nih.gov
      Categories: General Medicine News, Oncologists2
      Tweet Tweets with this article
      • Profile photo of 	scserendipity1
        scserendipity1

        RT @APCCC_Lugano: Evolving Risk of Urinary Adverse Events Across Localized Prostate Cancer Treatments https://t.co/gWYTck0RGg This large…

    • Mashup Score: 8
      Home - ClinicalTrials.gov - 13 day(s) ago

      Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information. ClinicalTrials.gov is a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world. ClinicalTrials.gov is a resource provided by the U.S. National Library of Medicine. IMPORTANT: Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Search for

      Source: clinicaltrials.gov
      Categories: General Medicine News, Oncologists2
      Tweet Tweets with this article
      • Profile photo of 	drcmassard
        drcmassard

        RT @jillfeldman4: The most experienced patients & advocates struggle to search for #clinicaltrial, even on https://t.co/ZNn0IP9nxh. A user-…

    • Mashup Score: 0
      ASCO Day 4: The Birmingham Screwdriver | Richard Simcock - 15 day(s) ago

      The Birmingham Screwdriver, chemo before lunch and the joy of sex. My final round-up from ASCO. Thanks for everyone who said hello and for all the great conversations Dr Olubukola Ayodele Dr Anna Olsson-Brown Alison Berner Liz O’Riordan Michael Jefford Stuart McIntosh Bhavisha Pandya Geni Auret Arti T. Kia Harding (née Matthews) Alice Lin Pomponio Fumiko Ladd Chino Shail Maingi Xi Cheng

      Source: www.linkedin.com
      Categories: General Medicine News, Oncologists2
      Tweet Tweets with this article
      • Profile photo of 	BreastDocUK
        BreastDocUK

        The Birmingham Screwdriver My thoughts from Day 4 of #ASCO25 https://t.co/mXoYMFCaCu

    • Mashup Score: 0
      Novocure study shows improved pancreatic cancer survival - 15 day(s) ago

      Novocure (Nasdaq:NVCR) today announced positive results from the Phase 3 PANOVA-3 trial of its tumor-treating fields (TTFields) therapy.

      Source: www.massdevice.com
      Categories: General Medicine News, Oncologists2
      Tweet Tweets with this article
      • Profile photo of 	weldeiry
        weldeiry

        Novocure study shows improved pancreatic cancer survival https://t.co/h32NUNC8Nc

    • Mashup Score: 3
      Longitudinal and multisite sampling reveals mutational and copy number evolution in tumors during metastatic dissemination - 15 day(s) ago

      Nature Genetics – A pan-cancer analysis of genomic data from matched primary and metastatic tumors from 3,732 patients shows that increased genomic complexity and alterations that facilitate immune…

      Source: www.nature.com
      Categories: General Medicine News, Oncologists2
      Tweet Tweets with this article
      • Profile photo of 	weldeiry
        weldeiry

        Longitudinal and multisite sampling reveals mutational and copy number evolution in tumors during metastatic dissemination CNA versus mutational accumulation is “enriched during cancer metastasis” “associated with immune evasion…with immunotherapy” https://t.co/hZz3YFiOKE

    • Mashup Score: 39
      Program Guide – ASCO Meeting Program Guide - 16 day(s) ago

      Daneng Li City of Hope National Comprehensive Cancer Center, Duarte, CA Daneng Li, Sun Young Kim, Manish Patel, Hee Kyung Kim, Sunil Sharma, Sang Joon Shin, Jeeyun Lee, Sae-Won Han, Luke Chung, Songmao Zheng, Yan Li, Ping Xiao, Kristine She, Dana HuLowe, Jiangchun Xu, Stanley Frankel, Michael Chisamore, Peter Luo, Jiping Zha, Marwan Fakih City of Hope National Comprehensive Cancer Center, Duarte, CA, Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea,

      Source: meetings.asco.org
      Categories: General Medicine News, Oncologists2
      Tweet Tweets with this article
      • Profile photo of 	pashtoonkasi
        pashtoonkasi

        #ASCO25 Continuing with the #immunotherapy promise for the🆕subset of patients with NO active LIVER METASTASES ➖NLM MSS🧊colorectal cancer, see 👀 this👇🏽 ➡️ADG126 Masked CTLA4⛔️➕Pembro ORR ~ 2️⃣9️⃣%❗️Sustained📉. FRUQ 💊➕Immunotherapy arm. https://t.co/SUFt4ZSkDX @OncoAlert https://t.co/sjICYAhpZp

    • Mashup Score: 23
      Program Guide – ASCO Meeting Program Guide - 16 day(s) ago

      Tadana Vazquez Rothschuh Ponce Health Sciences University, Ponce, PR, Puerto Rico Tadana Vazquez Rothschuh, Keishla Arce-Ruiz, Steve Sutton, Avani Singh, Jenifer Ryan, Ashley Oates, B Green, Jhanelle Gray, Shannon Christy, Vani Simmons, Bruna Pellini Ponce Health Sciences University, Ponce, PR, Puerto Rico, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, H Lee Moffitt Cancer Center, Tampa, FL Bristol Myers Squibb Foundation, Fundacion Intellectus, National Cancer Institute/U.S. National

      Source: meetings.asco.org
      Categories: General Medicine News, Oncologists2
      Tweet Tweets with this article
      • Profile photo of 	BrunaPellini
        BrunaPellini

        #ProudMentor moment at #ASCO25 with the absolute stellar 💫 #TadanaVázquez who presented our poster on tailored education on #clinicaltrials for minority patients. If you did not have a chance to check her poster today, you can download it here 👇🏼👇🏼👇🏼 https://t.co/ODiws25DuG A https://t.co/DrPYSPSvtF

    • Mashup Score: 4
      Structured Exercise after Adjuvant Chemotherapy for Colon Cancer | NEJM - 16 day(s) ago

      Preclinical and observational studies suggest that exercise may improve cancer outcomes. However, definitive level 1 evidence is lacking. In this phase 3, randomized trial conducted at 55 centers, …

      Source: www.nejm.org
      Categories: General Medicine News, Oncologists2
      Tweet Tweets with this article
      • Profile photo of 	clearyonc
        clearyonc

        RT @RyanNipp: Structured Exercise after Adjuvant Chemotherapy for Colon #Cancer. https://t.co/Q0SW3xvGeF @NEJM @ASCO #ASCO25 #ColonCan…

    • Mashup Score: 34
      Physical activity and survival after colorectal cancer diagnosis - PubMed - 17 day(s) ago

      Recreational physical activity after the diagnosis of stages I to III colorectal cancer may reduce the risk of colorectal cancer-specific and overall mortality.

      Source: pubmed.ncbi.nlm.nih.gov
      Categories: General Medicine News, Oncologists2
      Tweet Tweets with this article
      • Profile photo of 	SunnieSKim
        SunnieSKim

        I have been naming this for years as the top patient intervention to reduce the risk of colorectal cancer recurrence. Ever since this study was published: https://t.co/oV9YoMI2ao https://t.co/UI2l1wesHR

    • Mashup Score: 0
      Dr. Oz on the future of Medicaid, Trump’s megabill and AI avatar health care - 17 day(s) ago

      Podcast Episode · The Conversation with Dasha Burns · 06/01/2025 · 47m

      Source: podcasts.apple.com
      Categories: General Medicine News, Oncologists2
      Tweet Tweets with this article
      • Profile photo of 	drsmags
        drsmags

        Not a fan of Dr Oz per se but a very interesting interview. Note about advocating patient self education: refers them to Mayo or NIH or CC. NOT to Google or social media. Appreciate that point: the source matters. Also: your doctor should teach you! 100% https://t.co/6inpASwaGT

    Load More
    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings